NED:JSENedbank Group Analysis
Data as of 2026-06-09 - not real-time
ZAC 25,820.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Nedbank is trading just above its 20‑day SMA at 25,820, with the price also marginally above the 200‑day SMA, while sitting below the 50‑day SMA, indicating a modest short‑term upside. The MACD histogram is positive and the signal line has turned bullish, supporting a near‑term momentum tilt, but the RSI sits at 48.9, suggesting the stock is not yet overbought. Volume is on a decreasing trend and the 30‑day volatility of 16.7% is higher than typical for a low‑beta (0.16) security, hinting at modest liquidity pressure. Valuation appears attractive: the trailing P/E of 15.7 is below the industry average of 16.9 and the forward P/E of 6.3 signals significant earnings upside expectations. Dividend yield remains high at 8.6%, yet the payout ratio exceeds 120%, raising concerns about sustainability. Revenue has contracted by nearly 20% YoY, operating cash flow is negative, and net debt exceeds R105 bn, which together temper the bullish technical signals.
Overall, the stock sits at a crossroads where technical momentum is mildly positive but fundamental headwinds – declining earnings, high leverage, and an unsustainable dividend policy – dominate the outlook. The sector’s regulatory environment adds medium‑to‑high risk, and South Africa’s macro‑economic backdrop contributes additional geographic and currency exposure. Investors should therefore approach Nedbank with caution, weighing the short‑term technical upside against longer‑term fundamental challenges.
Overall, the stock sits at a crossroads where technical momentum is mildly positive but fundamental headwinds – declining earnings, high leverage, and an unsustainable dividend policy – dominate the outlook. The sector’s regulatory environment adds medium‑to‑high risk, and South Africa’s macro‑economic backdrop contributes additional geographic and currency exposure. Investors should therefore approach Nedbank with caution, weighing the short‑term technical upside against longer‑term fundamental challenges.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD crossover with positive histogram
- Price just above 20‑day SMA indicating limited upside
- Decreasing volume and moderate volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Revenue decline of ~20% and negative operating cash flow
- High net debt relative to equity
- Attractive forward P/E suggesting earnings recovery potential
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Unsustainable dividend payout ratio above 120%
- Regulatory and macro‑economic risks in South Africa
- Low beta but elevated sector and geographic risk
Key Metrics & Analysis
Financial Health
Revenue Growth-19.40%
Profit Margin13.01%
P/E Ratio15.7
ROE7.44%
ROA0.63%
P/B Ratio1.0
Op. Cash FlowZAC-103939997696
Industry P/E16.9
Technical Analysis
TrendNeutral
RSI48.9
SupportZAC 25,112.00
ResistanceZAC 29,315.34
MA 20ZAC 25,661.55
MA 50ZAC 26,333.50
MA 200ZAC 25,621.24
MACDBullish
VolumeDecreasing
Fear & Greed Index88.98
Valuation
Target PriceZAC 30,872.22
Upside/Downside19.57%
GradeUndervalued
TypeValue
Dividend Yield8.62%
Risk Assessment
Beta0.16
Volatility16.70%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.